Study to compare Bupivacaine heavy, Levobupivacaine plain and Levobupivacaine heavy with Fentanyl (opioid) as an add on drug under spinal anesthesia in Prostate surgery.
- Conditions
- Benign prostatic hyperplasia withlower urinary tract symptoms,
- Registration Number
- CTRI/2023/06/054367
- Lead Sponsor
- Dr Sanyukta Paul
- Brief Summary
This is a prospective randomized study comparing low dose intrathecal Levobupicaine 0.5% heavy, Levobupivacaine 0.5% plain and Bupivacaine 0.5% heavy with Fentanyl as an adjuvant in Transurethral resection of prostate surgeries. In this study, we are comparing the onset and duration of motor block and sensory block, to study intraoperative hemodynamics and to study the untoward side effects,if any.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Male
- Target Recruitment
- 105
Patient giving consent to participate in study Age between 50-75 years Weight between 45-70 kg ASA grade I and II Patient scheduled for TURP surgeries.
- Patients not giving consent to participate in the study.
- Uncooperative patient ASA grade III and IV Patients with respiratory, cardiovascular, renal diseases, obesity.
- Neurological disease (multiple sclerosis, symptomatic lumbar herniated disc, spinal stenosis) Coagulopathy Patient with known hypersensitivity to local anaesthetic.
- Local sepsis or infection.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Expected prolonged efficacy of Levobupivacaine 0.5% heavy over Bupivacaine 0.5% heavy & Levobupivacaine 0.5% plain 24 hours
- Secondary Outcome Measures
Name Time Method Expected lesser side effects & stable hemodynamic profile with Levobupivacaine 0.5% heavy than Bupivacaine 0.5% heavy and Levobupivacaine 0.5% plain 24 hours
Trial Locations
- Locations (1)
Gajraraja Medical College and Jayarogya Hospital, Gwalior
🇮🇳Gwalior, MADHYA PRADESH, India
Gajraraja Medical College and Jayarogya Hospital, Gwalior🇮🇳Gwalior, MADHYA PRADESH, IndiaDrSanyukta PaulPrincipal investigator8827430031sanyuktasaivikash@gmail.com